PART I // Microbiome: new efficacy and toxicity endpoint in clinical study Webinar presented by: - SPEAKER: Françoise...
Webinar
WEBINAR: Adaptive designs in Clinical Trials
A Biofortis webinar on adaptive designs in clinical trials Webinar presented by: - Hélène Chevallier: Clinical...
Too deep or not too deep?
A Biofortis webinar on how many sequencing reads you really need for your microbiome study Webinar presented by Thomas...
![[WEBINAR] Exploring the microbiome: Part 2// Bioinformatics and Data Science: From raw data to conclusions](https://www.biofortis.fr/wp-content/uploads/2020/12/Post-SM_webinar_post1-400x250.jpg)
[WEBINAR] Exploring the microbiome: Part 2// Bioinformatics and Data Science: From raw data to conclusions
Exploring the microbiome: Part 2// Bioinformatics and Data Sciences : From raw data to conclusions Many nutritional or drug intervention strategies can modulate the microbiome. This topic highlighting the microbiome analysis will be splitted in two different...
The Microbiome: new efficacy and toxicity endpoint in clinical studies
PART I // Microbiome: new efficacy and toxicity endpoint in clinical study Webinar presented by: - SPEAKER: Françoise Le Vacon: Chief Scientific Officer - MODERATOR: Stéphane Deniau: Business Manager Exploring the microbiome: from sample to data analysis Many...
WEBINAR: Adaptive designs in Clinical Trials
A Biofortis webinar on adaptive designs in clinical trials Webinar presented by: - Hélène Chevallier: Clinical Methodologist - Florence Gillaizeau: PhD-Biostatistician - Stéphane Deniau: Business Manager Adaptive designs receive a great deal of attention in the...
Too deep or not too deep?
A Biofortis webinar on how many sequencing reads you really need for your microbiome study Webinar presented by Thomas Carton Biofortis, a Mérieux NutriSciences Company Deep in metagenomics study of the microbiome (definitions) Raw Depth is not Usable Depth (steps...